Ship-Shape Management at Debiopharm
Debiopharm partnered with Dotmatics to implement a centralized research-data platform that unites data from all sites and CROs, streamlines workflows by enabling experiment cloning and result sharing, and improves decision-making through enhanced collaboration and reliable data access, thereby accelerating the delivery of new therapies to patients.
Debiopharm has a clear goal—Deliver new therapies to patients faster.
But the path to success is often complicated. Many obstacles can stand in the way. Endless data. Disconnected teams. No centralized research platform. It can be challenging enough to manage internal processes, let alone truly leverage people and knowledge to drive innovation.
To address these challenges, Debiopharm worked with Dotmatics to adopt several solutions and implement a centralized research-data platform that helped:
- Unite data – API, project, and experimental data from all sites and CROs instantly accessible
- Streamline workflows – Ability to search prior work, clone experiments, and share results
- Improve decision-making – Easier collaboration and reliable data to guide projects
Details of this company-wide implementation can be found in the case study, Dotmatics as a Disruptive Technology at Debiopharm. In this case study, Jean Richardson (IT Scientist at Debiopharm) shares a closer look at how Debiopharm got a better handle of their API stock and shipment process with the help of Dotmatics.
Related
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.
Sygnature Discovery Optimizes CRO Workflows with Dotmatics ELN Platform
Sygnature Discovery enhanced its global drug discovery operations by implementing the Dotmatics ELN and Data Discovery Platform, which provided customizable workflows, centralized data management, automated lab processes, and client-facing transparency tools, resulting in improved collaboration, efficiency, and real-time project visibility.
Data Management, Collaboration, and Workflow Optimisation: The Three Keys to Small Molecule Discovery Success
The article emphasizes that despite biologics' prominence, small molecule drug discovery is experiencing a renaissance driven by advances in screening, target exploration, and AI, but overcoming challenges like rising costs, data management, fragmented workflows, and CRO reliance requires success in three key areas: next-generation data management, enhanced cross-disciplinary research collaboration, and workflow optimization.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Lessons From The Past Year & My Opportunity to Spend More Time with You
Over the past year since the merger of Dotmatics and Insightful Science, the CEO has focused on building a strong leadership team and strategic acquisitions to enhance customer value, emphasizing the importance of a shared mission over just a shared vision to unify teams and drive purpose-driven work that supports scientific discovery, while acknowledging ongoing integration challenges and the benefits of their chosen M&A approach.